跳至主要内容
临床试验/ACTRN12623000670673
ACTRN12623000670673招募中3 期

An open-label randomised controlled trial of as-needed budesonide-formoterol vs. salbutamol reliever therapy in preschool children with mild asthma/recurrent wheeze.

The University of Auckland0 个研究点目标入组 280 人开始时间: 2023年6月21日最近更新:

试验速览

阶段
3 期
状态
招募中
入组人数
280

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomised controlled trial
主要目的
Treatment
盲法
Open (masking not used)

入排标准

年龄范围
24 Months 至 59 Months(—)
性别
All

入选标准

  • 1. Aged 24 to 59 months; AND
  • 2. >=3 wheezing episodes in the last 12 months (at least one doctor or nurse prescriber diagnosed); AND
  • 3. Prescription of SABA in the last 12 months.

排除标准

  • 1. Previous life-threatening asthma/wheeze (intensive care unit admission or intravenous treatment); OR
  • 2. Self-reported use of more than six SABA MDIs in the last 12 months (i.e. poorly controlled); OR
  • 3. Use of asthma medications other than SABA or ICSs (LABA, leukotriene receptor antagonist, theophylline, anticholinergic agent or cromone) in last 3 months; OR
  • 4. Significant other comorbidity including, but not limited to, cystic fibrosis and bronchiectasis or arrhythmia; OR
  • 5. Unable or unwilling to switch from current treatment regimen; OR
  • 6. Ex-preterm infant (born <37 weeks' gestation); OR
  • 7. Children living outside urban areas (i.e. significant distance from ambulance or hospital).

研究者

相似试验

已完成
4 期
A comparative study of the effects of Liraglutide and Acarbose on glycaemic control, weight and Health Related Quality Of Life (HRQOL) in Overweight type 2 Diabetic patients on Oral Hypoglycaemic Agents (OHAs) and high doses of insulin.
ISRCTN47355247West Wales Hospital (UK)66
尚未招募
不适用
Comparing standard treatment with topical anaesthetic cream in the treatment of postherpetic neuralgia
CTRI/2021/01/030847Dr R Sivayogana
已完成
不适用
An open-label, randomized, controlled trial to assess the efficacy and safety of teprenone in chronic hepatitis C patients concurrent with chronic gastritis treated with peginterferon alpha-2b plus ribavirin.Chronic hepatitis C patients with genotype 1 and high viral load (&gt= 5 Log IU/mL) concurrent with chronic gastritis.
JPRN-UMIN000001391Department of Gastroenterology and Hepatology, Okayama University Hospital200
进行中(未招募)
不适用
A randomised, controlled, open-label trial to compare brachial artery reactivity and cardiovascular risk of a treatment simplification by darunavir/ritonavir (DRV/r) 800/100 mg O.D. versus a triple combination therapy containing DRV/r in HIV-1 infected subjects with undetectable plasma HIV-1 RNA on their current treatments. - ND
EUCTR2008-002383-34-ITJANSSEN-CILAG
进行中(未招募)
不适用
A randomised, controlled, open-label trial to compare the efficacy, safety and tolerability of a treatment simplification by darunavir/ritonavir (DRV/r) 800/100 mg O.D. versus a triple combination therapy containing DRV/r in HIV-1 infected subjects with undetectable plasma HIV-1 RNA on their current treatments.HIV-1MedDRA version: 9.1Level: LLTClassification code 10020161Term: HIV infection
EUCTR2006-006437-40-ATJanssen-Cilag International NV250